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Abstract
Mucus accumulation is a feature of inflammatory airway disease in the horse and has been associated with reduced
performance in racehorses. In this study, we have analysed the two major airways gel-forming mucins Muc5b and Muc5ac in
respect of their site of synthesis, their biochemical properties, and their amounts in mucus from healthy horses and from
horses with signs of airway mucus accumulation. Polyclonal antisera directed against equine Muc5b and Muc5ac were
raised and characterised. Immunohistochemical staining of normal equine trachea showed that Muc5ac and Muc5b are
produced by cells in the submucosal glands, as well as surface epithelial goblet cells. Western blotting after agarose gel
electrophoresis of airway mucus from healthy horses, and horses with mucus accumulation, was used to determine the
amounts of these two mucins in tracheal wash samples. The results showed that in healthy horses Muc5b was the
predominant mucin with small amounts of Muc5ac. The amounts of Muc5b and Muc5ac were both dramatically increased in
samples collected from horses with high mucus scores as determined visually at the time of endoscopy and that this
increase also correlated with increase number of bacteria present in the sample. The change in amount of Muc5b and
Muc5ac indicates that Muc5b remains the most abundant mucin in mucus. In summary, we have developed mucin specific
polyclonal antibodies, which have allowed us to show that there is a significant increase in Muc5b and Muc5ac in mucus
accumulated in equine airways and these increases correlated with the numbers of bacteria.
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Introduction
The gel-forming, epithelial mucins are large polymeric
glycoproteins that are a major structural component of the mucus
barrier, which forms a protective interface against the external
environment. Their major role is to maintain hydration of the
airway epithelium and to provide a milieu to entrap external
agents, both biological (allergens and bacteria) and chemical
(particles and pollutant gases), which can then be removed from
the airways by mucociliary clearance. The two most common
inflammatory respiratory syndromes of horses are recurrent
airway obstruction (RAO) and inflammatory airway disease
(IAD). These conditions are characterized by airway mucus
over-production and impairment in mucociliary clearance. RAO,
associated with chronic exposure to environmental allergens,
predominantly affects middle-aged to older (usually $7 years old)
housed horses [1] with the prevalence of the condition increasing
with age [1,2,3,4]. Reduced airflow is associated with broncho-
constriction, mucus hypersecretion and airway neutrophilia
[2,5,6,7,8]. Clinical signs range from slight exercise intolerance
to dyspnoea at rest. Episodes may be reversed or alleviated by drug
therapy or changes to management resulting in improved air
quality [5,9,10]. Young racehorses in training suffer from IAD, a
condition that also involves airway neutrophilia and increased
amounts of tracheal mucus [11,12,13,14]. Clinical signs of
IAD include coughing [11,12] and poor racing performance
[15,16,17,18,19].
We have shown previously that Muc5b and Muc5ac are the
predominant mucins in airway secretion from healthy horses [20].
However, while mucus accumulation in the airways is associated
with IAD and RAO and contributes to the pathological symptoms,
little is currently known about the gel-forming mucins in these
conditions and how they contribute to the aberrant clearance of
mucus. As in the horse, the orthologous mucins, MUC5B and
MUC5AC, are the major gel-forming mucins in human airway
mucus [21,22]. In normal airway epithelium the expression of the
two mucins is cell specific; MUC5B is mainly expressed by the
submucosal glands, and MUC5AC expressed by the goblet cells at
the surface epithelium [22,23]. In human pathological conditions,
such as asthma, chronic obstructive pulmonary disease (COPD)
and cystic fibrosis (CF), mucin expression is altered with an
increase in the amounts of both MUC5B and MUC5AC.
Furthermore, MUC5B was more abundant in mucus obstructing
the airways [24,25,26]. In addition, in vitro studies have also shown
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19678that the regulation of these two mucins can be altered by
inflammatory mediators such as cytokines, and directly by external
challenges such as bacteria [27,28,29,30,31].
The studies on human airway mucus have highlighted that the
gel-forming mucin composition and concentration in mucus likely
impacts on its efficient clearance from the respiratory tract. While
in-roads have been made in the understanding of human airway
mucus there are many unanswered questions relating to equine
airway mucins and mucus. For example, what are the sites of
synthesis of these mucins? Which mucins are up-regulated in
hypersecretory conditions, in particular in IAD? What is the
composition of mucus that accumulates in the airways? To address
these issues we have raised and characterised antisera specific to
equine Muc5b and Muc5ac. We have shown that in normal
equine trachea, Muc5ac and Muc5b are products of both
epithelial goblet cells and cells in the submucosal glands. Both
mucins contributed to mucus accumulated in the airways of a
cohort of Thoroughbred racehorses, although Muc5b was
generally present in higher amounts.
Results
In our previous work, we used mass spectrometry to
demonstrate that Muc5b and Muc5ac are the major polymeric
mucins in equine airway mucus [20]. However, no tools were
available to distinguish between these two mucins in mucus, or in
respiratory tissue. In the present study, our aims were to develop
antibody probes specific for Muc5b and Muc5ac in order to
determine the sites of synthesis of Muc5ac and Muc5b in equine
upper airways, to characterise the biochemical properties of the
two mucins, and to determine the relative amounts of Muc5ac and
Muc5b in mucus collected from horses with and without signs of
mucus hypersecretion.
Characterisation of mucin-specific antisera
Polyclonal antisera were raised against peptides located within
the putative non-glycosylated, cysteine-rich domains of the central
regions of Muc5b (MANeq5b-I; DEDYPTSEKAGGDIEC) and
Muc5ac (MANeq5ac-I; GIDSGDFDTLENLR). These peptides
were selected after analysis of the putative equine Muc5ac and
Muc5b gene sequences [20] to ensure that each sequence was
specific for its respective mucin. To test if the antisera could
discriminate between Muc5ac and Muc5b we performed immu-
nohistochemical analysis of equine tissues that differentially
express the two mucins. Salivary and gastric tissues were studied
since Real-Time (RT) PCR data showed that Muc5ac was highly
expressed in gastric tissue and Muc5b was not detected, whereas
Muc5b was expressed in salivary glands and Muc5ac was not
detected (Table 1). This is in accordance with published data from
horse, human and other species [20,32,33].
Sections of dorsal buccal salivary glands and gastric tissue were
examined. PAS-AB staining of these tissues was first used to
identify the glycoprotein containing cells. In dorsal buccal salivary
glands, there was strong staining of the majority of the cells with
PAS-AB (Figure 1A) and in the glandular gastric tissue, surface
mucous cells and cells in the deeper glands showed staining with
PAS-AB (Figure 1E). Similar sections were stained with protein-A
purified MANeq5b-I and MANeq5ac-I sera. As expected from the
mRNA data, salivary gland cells were strongly stained with
MANeq5b-I (Figure 1B) but not stained with MANeq5ac-I
(Figure 1C), whereas gastric tissue showed no staining with
MANeq5b-I (Figure 1F) but showed strong staining of the surface
epithelial cells with MANeq5ac-I (Figure 1G). Pre-incubation of
each antiserum with the peptide used for immunisation abolished
immunohistochemical staining (Figure 1D and H), supporting
their ability to discriminate between the two mucins.
Biochemical characterisation of Muc5ac and Muc5b
In order to characterise Muc5ac and Muc5b, four tracheal wash
samples from horses showing signs of mucus hypersecretion were
pooled, solubilised in 4M guanidinium chloride and analysed by
caesium chloride density gradient centrifugation (buoyant density),
anion exchange chromatography (charge distribution) and rate-
zonal sedimentation (size distribution). PAS staining of fractions
across the density distribution (Fig. 2A) showed that mucins were
enriched in the high buoyant density fractions (1.37–1.55 g/ml).
The mucins in fraction 5 were reduced and carboxymethylated
and subjected to agarose gel electrophoresis (Fig. 2B). A Western
blot of the gel probed with MANeq5b-I showed three bands. In
contrast, MANeq5ac-I detected a single, broad band that migrated
in a similar position to the fastest migrating Muc5b-band.
To investigate whether the separation between Muc5ac and
Muc5b was due to the charge density of the molecules the reduced
and carboxymethylated mucin preparation was subjected to anion
exchange chromatography (Fig. 3). This method has been used
previously to separate human airway mucins [34,35]. The total
glycoprotein profile was assessed by PAS staining and showed that
the molecules had a broad distribution of charge density. Fractions
from across the chromatogram were also analysed by immuno-
blotting using MANeq5ac-I and MANeq5b-I (Figure 3). The
reactivity profiles of the two antisera showed different but
overlapping distributions. MANeq5ac-I-reactive material was
present in two peaks; one major peak (fractions 15-25) and a
more minor peak (fractions 26–40). In contrast, MANeq5b-I
reactive material was confined to a single, broad peak (fractions
16–40). As expected from the antibody profiles, tandem mass
spectrometry analysis of tryptic peptides derived from the Muc5ac-
enriched peak (fraction 20) and the Muc5b-enriched peak (fraction
29) showed that Muc5ac was present in fraction 20 (2 Muc5ac
peptides, no Muc5b peptides) and Muc5b and Muc5ac were
present in fraction 29 (8 Muc5b peptides, 3 Muc5ac peptides).
These data indicate that the two antibody probes can be used to
discriminate between Muc5ac and Muc5b in immunoblotting
experiments. Furthermore, the major population of Muc5ac is
more lowly charged than Muc5b, with Muc5ac showing evidence
of different charged variants (or glycoforms).
To analyse the size distributions of Muc5ac and Muc5b mucins,
airway mucus (pooled from 4 horses with airway mucus
accumulation) was subjected to rate-zonal centrifugation, before
and after treatment with a reducing agent (10 mM DTT). The
unreduced Muc5ac and Muc5b mucins were characterized by a
Table 1. Real-Time PCR results obtained from mRNA
extracted from salivary glands, trachea and stomach showing
differential expression of the Muc5b and Muc5ac in these
tissues.
Muc5ac Muc5b
Stomach 19.06 (64.8) ND
Trachea 0.108 (60.13) 3.541 (61.8)
Salivary gland ND 18.3 (63.2)
ND: not detectable
The data shown are raw expression normalized to GAPDH and SDHA
housekeeping genes.
doi:10.1371/journal.pone.0019678.t001
Mucins in Equine Airways
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19678Figure 1. Histological and immunohistochemical staining of equine salivary gland and stomach tissues. Panels A (salivary glands) & E
(stomach) show glycoprotein staining with PAS-AB. Sections from salivary glands (B–D) and stomach (F–H) were used to characterise the purified
antisera. Panels B & F show the staining of equine salivary gland tissue and stomach with MANeq5b-I and panels C & G show staining of these tissues
with MANeq5ac-I. Panels D & H show inhibition of antisera reactivity with the peptides used for immunisation. For the stomach sections, S indicates
the location of the surface mucous cells, and SG indicates the location of the submucosal gland tissue. All pictures were taken at 20X magnification
apart from panel D which was taken at 40X.
doi:10.1371/journal.pone.0019678.g001
Figure 2. Purification of Muc5ac and Muc5b by caesium chloride density gradient centrifugation. Tracheal washes were dissolved in
equal volume of 8 M guanidinium chloride and the mucins separated from other proteins by CsCl density gradient centrifugation. Panel A: Fractions
were analysed for optical density at 280 nm (open squares) and the mucin containing fractions were determined by PAS staining (black triangles).
The density of each fraction was determined by weighing (dashed line). Panel B: MANeq5b-I and MANeq5ac-I antisera were used to probe a Western
blot after agarose gel electrophoresis of the mucins in fraction 5.
doi:10.1371/journal.pone.0019678.g002
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distribution of mucins (Figure 4A). After reduction, the mucins
exhibited slower sedimentation rates. Interestingly, there was a
separation of the PAS-reactivity from a slower sedimenting
population of molecules that was highly reactive with the mucin
probes (Figure 4B).
Determination of the site of mucin synthesis
Immunohistochemical analysis of gastric and salivary mucins, as
well as the biochemical analysis of the mucins, has demonstrated
the specificity of the two polyclonal antisera. Therefore, we used
the two mucin-probes to analyse the sites of synthesis of mucin
production. Staining of normal tracheal tissue with PAS-AB
(Figure 5A) showed individual epithelial goblet cells stained both
pink (neutral mucins) and/or blue (acidic mucins). Within the
glands the PAS-AB staining is predominantly blue, indicating that
the mucins are mainly acidic (Figure 5D). Serial sections stained
with protein-A purified MANeq5ac-I (Figure 5B and 5E) and
MANeq5b-I (Figure 5C and 5F) showed that both mucins are
expressed in epithelial goblet cells (Figure 5B and 5C) and
submucosal gland cells (Figure 5E and 5F). Analysis of the staining
showed that the surface epithelium contained more goblet cells
positive for Muc5b than Muc5ac (approx. 1 cell staining for
Muc5b and approx. 0.5 cell staining for Muc5ac per 30 mmo f
surface epithelium, p=0.0003, Figure 5G). Furthermore, a higher
percentage area of the glands stained with Muc5ac than Muc5b
(21% and 11.5% respectively, p=0.0009, Figure 5H). It is not
clear whether both mucins are present in the same cells. For both
mucins, the antibody staining was abolished by inhibition with the
peptide used for immunisation.
Muc5b and Muc5ac in tracheal wash samples from
thoroughbred horses in training
The mucin-specific antisera were employed in a Western
blotting assay to analyse the Muc5ac and Muc5b content of
Figure 3. Separation of Muc5b and Muc5ac by anion exchange chromatography. Purified respiratory mucins were reduced and
carboxymethylated and dialysed into 6 M urea prior to anion exchange chromatography on a Resource Q column. Aliquots of each fraction were
analysed by PAS-staining (black triangles) and for reactivity with MANeq5b-I (black circles) and MANeq5ac-I (open circles). The dotted line indicates
the linear gradient of lithium perchlorate. Inset shows Muc5ac and Muc5b peptides identified by tandem mass spectrometry analysis of fractions 20
and 29.
doi:10.1371/journal.pone.0019678.g003
Figure 4. Sedimentation analysis of Muc5ac and Muc5b.
Unreduced (panel A) and reduced mucins (panel B) were subjected to
rate-zonal centrifugation on 6-8 M guanidinium chloride gradients.
Fractions were analysed for glycoprotein content by PAS-staining (black
triangles), and for reactivity with MANeq5b-I (black circles) and
MANeq5ac-I (open circles). Fractions 1 and 24 represent the top and
bottom of the gradient, respectively.
doi:10.1371/journal.pone.0019678.g004
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tracheal washes from four horses over the course of several
months. The Western blot results for seven tracheal wash samples
collected from one of the horses is shown in Figure 6A. The blot
showed a wide variation in the amount of the two mucins across
the sampling period and, furthermore, there was a variation in the
number and electrophoretic mobility of mucin bands. In general,
the variation in the amount of the mucins followed the amount of
mucus in each sample, determined endoscopically at the time of
sample collection (Figure 6B & C). However, this is not always the
case and for some tracheal wash samples the mucin content did
not follow the amount of mucus.
We next analysed the Muc5ac and Muc5b composition of 144
tracheal wash samples, collected from thoroughbred racehorses as
part of a wider study of IAD [36,37]. In the first series of
experiments, a 20 ml and a 40 ml aliquot of each sample was
analysed using the Western blot procedure. Approximately 50% of
the samples showed no staining with the antisera. These were
below the level of detection of the assay and were not studied
further (62 samples for Muc5ac and 71 samples for Muc5b). The
samples that gave a positive response in the assay were further
analysed by Western blotting (each sample was diluted 1:5, 1:10,
1:20 and 1:40) and the average staining intensity for MANeq5b-I
and MANeq5ac-I for each sample was determined. The analyses
Figure 5. Histological and immunohistochemical staining of normal equine tracheal tissue. 5 mm sections of tracheal tissue were stained
with (panels A and D) PAS, (panels B and E) MANeq5ac-I and (panels C and F) MANeq5b-I. In panels B, C, E and F the sections were reduced and
carboxymethylated prior to staining with protein-A purified antibodies. Panels A, B and C show the staining of the surface epithelium while panels D,
E and F show staining of the submucosal glands. Panels G and H show the quantitation of staining for PAS and the two antibodies. The analysis of the
staining was performed on three different horses. For the surface epithelium the goblet cell staining was determined for 96750 mm lengths of
epithelium. For submucosal gland staining a minimum of 6 glands per horse were analysed. The red line represents the average and the green line
the median.
doi:10.1371/journal.pone.0019678.g005
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reflecting Muc5ac and Muc5b content. The complete set of data
is shown in supplementary data (Table S1). The mucin content
showed a strong, positive association with the mucus score,
although this was not the case for all samples. Samples with a high
mucus score (mucus score 2 and 3) were found to have the highest
amounts of Muc5b and Muc5ac (p,0.001 for both) (Figure 7A &
B). There was also a strong, positive correlation between Muc5b
and Muc5ac (p,0.001) (Figure 7C), showing that samples
containing a high amount of Muc5b also had higher amounts of
Muc5ac (Figure 7C).
The total number of bacteria present in each tracheal sample
was also analysed against its mucin content showing that the
samples with increased amounts Muc5b and Muc5ac also had
higher total bacterial counts (Figure 8, p,0.001)). However, there
was no specific association with any individual bacterial species
such as Streptococcus zooepidemicus, S. viridians, non-haemolytic
Streptococcus spp or Staphylococcus spp (data not shown).
Muc5b is the main mucin in healthy and diseased
samples
While the compositional analyses reflect the mucin content of
each sample, they are not a quantitative measure of the amount of
mucin. In particular, the analyses are dependent on the sensitivity
of each antiserum. In order to establish the range of detection of
MANeq5ac-I and MANeq5b-I mucin, solutions of known
concentration were prepared. Horse gastric mucus was used as
the source of Muc5ac and horse saliva as the source of Muc5b.
Mucins were purified by caesium chloride density gradient
centrifugation and their mucin content, measured by refractom-
etry, was 73.5 mg/ml (gastric mucins) and 80 mg/ml (salivary
mucins). Tandem mass spectrometry showed that the gastric
mucin preparation contained Muc5ac. Surprisingly, although
Muc6 is expressed in the stomach along with Muc5ac, no peptides
for Muc6 were identified by tandem mass spectrometry, indicating
that Muc6 is not a major component of our preparation. The
salivary preparation contained both Muc5b and Muc19 mucins.
Figure 6. Variation of Muc5b and Muc5ac composition of tracheal washes from Thoroughbred horses in training. (Panel A): Seven
different tracheal wash samples collected from a single horse (Horse 1) in August, October, November, December 2004 and January, February and
April 2005 were reduced and carboxymethylated and subjected to agarose gel electrophoresis. Two dilutions of each sample (1/5 and 1/10) were
loaded onto a 0.7% agarose gel. A Western blot of the gel was probed for Muc5b with MANeq5b-I and Muc5ac with MANeq5ac-I. (Panels B and C):
Graphical representation of the mucus score attributed to each sample by endoscopy at the time of collection (black triangle and dotted line) and
MANeq5b-I (black circles) and MANeq5ac-I reactivity (open circle) after Western blotting across the sampling period for horse 1 (panel B) and for three
other horses (panel C).
doi:10.1371/journal.pone.0019678.g006
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Muc5b and Muc19 were used to determine the ratio of the two in
the purified mucin preparation in a similar manner to that used in
Water’s Expression
E approach [38]. Since there are no reports of
the molecular mass for equine Muc19 or Muc5b the following
three assumptions were made to estimate the relative amounts of
the two mucins in the preparation. Firstly, the estimated molecular
weight of the Muc19 polypeptide was approximately 840 kDa
based on the recent report by Chen and colleagues of the
estimated full-length sequence of the human MUC19 gene [39].
Secondly, the estimated molecular weight of the Muc5b
polypeptide was approximately 570 kDa based on the database
sequence of the human MUC5B polypeptide, Q9HC84. Thirdly,
both mucins had a similar percentage of their mass in the form of
carbohydrate. Based on these assumptions in conjunction with the
mass spectrometry data we calculated the mass ratio of Muc5b/
Muc19 ratio to be 1.3 (60.2), which indicates that the salivary
mucin solution contains approximately 45 mg/ml of equine
Muc5b.
A range of amounts of the two-mucin standard solutions was
electrophoresed and Western blots of the gels were probed with
either MANeq5ac-I or MANeq5b-I. The response curves
generated show that eqMuc5ac-I recognises substantially lower
levels of mucin than the eqMuc5b-I (Figure 9). MANeq5b-I
antibody detected between 0.1 to 10 mg of Muc5b while
MANeq5b-I detected between 10 to 1000 ng of Muc5ac
(Figure 9). A retrospective analysis of the data generated above
showed that Muc5b is the major mucin in the airway mucus, and
Figure 7. Correlation between mucus score and mucin amounts of tracheal washes from Thoroughbred horses in training. Graphical
representation of the mucus score versus the MANeq5b-I (panel A) and MANeq5ac-I (panel B) reactivity for each tracheal wash sample. On graphs A
and B, the samples are ordered first according to their mucus score then according to their MANeq5b-I reactivity. ANOVA analysis showed that there
was a strong association between the increase of the mucus score and the increase of the mucin antibody reactivity (p,0.001 for both mucins). For
the ANOVA analysis, samples from mucus score 2 and 3 were grouped due to low sample number in the mucus score 3 group. (Panel C): Graphical
representation of the correlation between Muc5b and Muc5ac content of tracheal wash samples (p,0.001).
doi:10.1371/journal.pone.0019678.g007
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more than 10-fold in tracheal wash samples from horses with
mucus accumulation, Muc5b remained the most abundant mucin
in the vast majority of samples analysed.
Discussion
We have generated antisera specific to the two major equine
airways polymeric mucins, Muc5ac and Muc5b. These probes
have been employed to distinguish between Muc5ac and Muc5b
by using immunohistochemistry of tissue sections, and by
immunoblotting after fractionation of tracheal mucus. Immuno-
histochemical staining has shown that in normal trachea Muc5b
and Muc5ac are both produced by cells in the submucosal glands
and surface epithelial goblet cells. At present, the relative
contribution of the submucosal glands and the goblet cell
secretions to the mucus layer is not known. The analysis of the
antibody staining data showed that more surface epithelial goblet
cells stained for Muc5b than Muc5ac. In contrast, the submucosal
glands showed more staining for Muc5ac than Muc5b. Of course,
due to the difference in sensitivity of our antisera (discussed below)
low amounts of Muc5b in the glands might not be efficiently
Figure 8. Correlation between mucin specific antibody reactivity and bacterial count. Top panel: Graphical representation of the
association between the MANeq5b-I response and the total bacterial counts (p,0.001) Bottom panel: graphical representation of the association
between the MANeq5ac-I response and the total bacterial counts (p,0.001).
doi:10.1371/journal.pone.0019678.g008
Mucins in Equine Airways
PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e19678detected. The distribution of Muc5b and Muc5ac in the horse is
unexpected, since this localisation data contrasts with the
distribution of the orthologues of these two mucins in human
upper airways, where MUC5B is expressed mainly in mucous cells
in the submucosal glands and MUC5AC is produced mainly by
the surface goblet cells [22,40]. However, we have only examined
normal tracheal tissue and have no data regarding the cellular
origins of these two mucins in the lower airways, nor in diseased
tissues. It will be important to determine the site of synthesis of
Muc5ac and Muc5b in horses with airway obstruction to inform
future therapeutic developments targeted at modulating mucin
production in horses with respiratory disease.
Analysis of Muc5ac and Muc5b by rate-zonal centrifugation
showed that both mucins had heterogeneous sedimentation
profiles, indicative of polydisperse size distributions. This is
consistent with previous findings which showed that equine
respiratory mucins are polymeric and heterogeneous in size [20]
as are their human counterparts [26,34,35,41]. After cleavage of
disulphide bonds, Muc5ac and Muc5b showed a marked decrease
in sedimentation rate, consistent with the effect of reducing agents
on human MUC5AC and MUC5B [26,34,35,41]. It is noteworthy
that after reduction, two populations of Muc5ac and Muc5b are
observed. The population with higher sedimentation rate most
likely represents the reduced mucin monomers (subunits;
[26,34,35,41]), whereas, the more slowly sedimenting molecules
may represent differently glycosylated populations of Muc5ac and
Muc5b, or protein-rich fragments of the mucin polypeptides
generated by proteolytic modification, as demonstrated for human
polymeric mucins [26,34,35,41].
Agarose gel electrophoresis identified at least three populations
of Muc5b, but these were not apparent in all samples. Under the
same conditions, human MUC5B showed two forms, which
resulted from differences in their charge density (low and high
charge glycoforms; [25,26]). However, anion exchange chroma-
tography of the equine mucins identified a single, broad peak for
Muc5b with no obvious evidence for distinct populations.
Interestingly, one heterogeneous band, with variable mobility
between horses, was observed after electrophoresis of Muc5ac. In
contrast, anion exchange chromatography identified two peaks.
The major peak exhibited a lower charge density than the more
minor population, and the majority of Muc5ac had a low charge
density but a high electrophoretic mobility. Therefore, unlike
human MUC5AC and MUC5B, the electrophoretic mobilities of
the equine orthologues do not correlate with charge density (as
assessed by anion exchange chromatography). These findings
show that the electrophoretic behaviour of the equine mucins is
not simply explained by their charge density. Other factors are
clearly important. For example, the molecular weight of the
mucins may impact on their electrophoretic migration. This could
be affected by the extent of glycosylation of the mucins or their
incomplete reduction that may have yielded multimeric species
rather than mucin monomers. Also, the binding of SDS to the
polypeptides may be different. This could be due to inherent
differences in the primary sequences of the mucin poypeptides or
might arise by proteolytic cleavage. These analyses have shown
that the major population of Muc5ac has a lower average charge
density than Muc5b. However, it is not known how this relates to
biological function. Potential differences in the glycosylation of the
mucins are likely to result in different interactions with respiratory
pathogens or with other components of the mucus. Whether the
latter impacts on the protective nature of mucus in terms of
mucociliary clearance remains to be elucidated. In humans,
changes in the glycosylation of MUC5B have been shown to occur
in CF and COPD, and a specific glycoform of MUC5B (low
charge glycoform) has been found to be more prevalent [25,26].
Again, it is not known how this impacts on mucus function.
However, a low charge MUC5B glycoform was the predominant
mucin in mucus that obstructed the airways in an individual who
died in status asthmaticus [42].
Analysis of the mucin composition in serial tracheal washes over
the course of 12 months revealed marked variations in the content
of Muc5ac and Muc5b. This trend generally reflected the amount
of mucus in the airways measured visually at the time of tracheal
washing. However, at some time-points the two did not match and
a small amount of mucus was not associated with a low level of the
mucins, and vice versa. This could be explained in a number of
Figure 9. Determination of the sensitivity of the MANeq5b-I and MANeq5ac-I antisera. Reduced and carboxymethylated mucin standard
solutions, prepared from saliva (Muc5b 10-0.02 ng) and from equine stomach mucus (Muc5ac, 1480-2.9 ng), were electrophoresed on 0.7% agarose
gels. Western blots of the gels were probed with MANeq5b-I (inset in panel A) and MANeq5ac-I (inset in panel B), the intensity of the staining was
measured by reflectance densitometry and is plotted against the amount of mucin.
doi:10.1371/journal.pone.0019678.g009
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secretion (eg. hyaluronan or proteoglycans that have been
observed in mucus produced in human airway disease
[43,44,45] may result in the visual appearance of mucus, (ii) the
washing procedure did not remove the mucus from the airways
(adherent mucus has been observed in the airways of animal
models of cystic fibrosis [46,47]), (iii) the mucus was in a form not
readily identified by endoscopy. This warrants further investiga-
tion in the future. It is also noteworthy that amongst the samples
from horses with no visible mucus in their trachea, some were
found to have detectable amounts of mucins (Figures 6 & 7). This
highlights a discrepancy between the amount of mucus identified
visually by endoscopy and the amount of mucins determined by
immunoblotting and might reflect a difference in the mucus
properties, or at least in mucus appearance. However, it could be
that the tracheal wash technique samples areas of the airway that
are not accessible with an endoscope, indicatingthat the mucin
specific analyses from tracheal washes could be of value for the
diagnosis of lower airway infection.
Analysis of the Muc5ac and Muc5b mucin composition of
mucus accumulated in the airways of a cohort of thoroughbred
racehorses showed that the Muc5b and Muc5ac content increased
with increasing amounts of mucus. Furthermore, the amount of
both mucins was increased in samples showing an increase in the
number of bacteria in the mucus. These observations may not be
too surprising and while the amounts of both mucins are
increased, the western blotting analyses were at best semi-
quantitative and do not reveal the actual amount of the mucins
and their fold-increase. Therefore, we addressed this issue
retrospectively by preparing standard solutions of Muc5ac and
Muc5b to characterise further the polyclonal antisera. This
showed that MANeq5ac-I was able to detect approximately 20-
fold less mucin than MANeq5b-I and thus Muc5b was the major
mucin in all the samples analysed. We are aware that this
conclusion relies on several assumptions that were made in
determining the concentration of the mucin standards. In the case
of the gastric mucin preparation (Muc5ac standard) only Muc5ac
was identified by mass spectrometry. This was unexpected because
in the human MUC6 is highly expressed in the deeper glands of
the stomach and we therefore expected to find Muc6 in our
preparation [48]. However, in agreement with our finding
MUC5AC but no MUC6 was detected in mucus harvested by
gentle scraping of the human gastric epithelium [49], a similar
approach to that used here to collect the equine mucus. Of course,
we cannot conclude that Muc6 was absent from the gastric mucin
preparation but we can conclude that Muc5ac was the major
mucin in the standard solution. Consequently, we may have
slightly overestimated the amount of Muc5ac in the standard
solution, resulting in an underestimation of the amount of Muc5ac
in the samples. Unlike the Muc5ac standard, the Muc5b standard
solution (prepared from saliva) is a mixture of the two mucins
Muc5b and Muc19. Ideally we would have separated the two
mucins but this was not possible using current separation
methodologies (data not shown). Therefore, we calculated the
concentration of each mucin in the standard solution from tandem
mass spectrometry data and employing the current information on
human MUC5B and MUC19 mucins to predict the molecular
weight of the mucin polypeptides [39,50,51].
Despite the issues mentioned above, the data are in accordance
with the real time PCR data presented here, and with the
previously published mass spectrometry analyses of equine airway
mucins indicate that Muc5b is the major polymeric mucin
expressed [20]. This is also in agreement with observations made
in other animals. For example, in unchallenged mice airways it has
been reported that Muc5b is more abundant than Muc5ac [52,53]
and Young and co-workers have reported that Muc5b mRNA was
40 fold more abundant than Muc5ac mRNA [54].
While this is the first study to report on the gel-forming mucin
composition of equine airway mucus, one should be aware that
there are limitations to the approach employed. First of all, it is
worth pointing out that for a number of samples no mucin was
detectable. However this is dependent on the sensitivity of the
antibody used to detect the mucins. In the case of Muc5b, we
found that the antibody is not very sensitive and cannot detect
reliably amounts lower than 100 ng, while the eqMuc5ac antibody
is more sensitive and can detect as little as 10 ng. This means that
in the samples where mucus can be seen, but no mucins were
detected, it is possible that the mucus present is composed mainly
of Muc5b, in amounts lower than the sensitivity of our assay.
Another potential problem is cross-reactivity of the antisera with
other polymeric mucins. However, this should not be an issue
when analysing airway tissue sections and secretions because
Muc5ac and Muc5b are the major polymeric mucins found in
equine airway mucus, and tandem mass spectrometry analysis
presented here and previously [20] have not identified other
polymeric mucins. Furthermore, tandem mass spectrometry
analysis of the mucins present in the secretions pooled from the
10 highest mucus score samples did not identify peptides from any
polymeric mucin (Muc2, Muc6 nor Muc19) other than Muc5b
and Muc5ac (data not shown).
Despite these limitations, our study has highlighted major
increases of both Muc5ac and Muc5b mucins. How these changes
impact on the mucus properties in terms of barrier function and
transport is not known. However, studies performed on human
sputum may shed some light on these issues. Several studies have
shown that the mucin composition of sputum expectorated from
human patients suffering from asthma, chronic obstructive
pulmonary disease (COPD) and cystic fibrosis (CF) is altered
[24,25,26]. Importantly, in a study of COPD, the relative amounts
of MUC5AC and MUC5B were shown to differ in smokers with
and without airway obstruction [26], suggesting that the mucin
composition of mucus is a major factor for efficient mucus
transport.
Other studies have analysed the expression of Muc5ac in horses
with RAO and have yielded contradictory data, with an increase,
or no change in Muc5ac expression being reported [55,56].
Increased Muc5ac expression seems more likely since the data
reporting no change in Muc5ac expression were obtained from
broncheoalveolar lavage fluid rather than epithelial tissue.
Nevertheless, in these two studies, the expression of Muc5b was
not determined and it is possible that Muc5b alone is responsible
for the mucus accumulation in RAO. The work presented here
demonstrates that Muc5b is much more abundant than Muc5ac in
healthy as well as in diseased horses, which indicates that it is
essential to consider both Muc5b and Muc5ac when examining
changes in mucus.
To conclude, the work presented here shows that there is an
increase in both Muc5ac and Muc5b in the mucus accumulated in
equine airways. The critical steps that lead to mucus overproduc-
tion remain to be elucidated. Understanding of mechanisms of
inflammation and response to pathogens has been greatly
advanced by the development of cell culture models and in
particular the air-liquid interface model culture of primary airway
epithelial cells [57,58]. Development of this culture model for
equine airways epithelial cells, combined with the polyclonal
antisera described here would be invaluable for unravelling the
biological events leading to mucus overproduction in horses and
possibly man.
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Mucin gene expression in salivary glands, trachea and
stomach
Equine tissues were dissected within one hour after death from
clientownedhorseseuthanasedforclinicalreasonsnotrelatingtothe
respiratory tract, which demonstrated no clinical or pathological
signs of respiratory diseases. Full informed consent was obtained
from the owners of the horses following internal ethical review.
Additionaltissuewasobtainedpost-mortemfromanequineabattoir.
No horses were euthanased specifically for this study. The tissues
were snap frozen in liquid nitrogen, ground into a fine powder using
a micro-dismembranator and then transferred to TRI reagent. RNA
extraction was then carried out using the phenol/choloroform
method of Chomczynski [59] and total RNA was purified using the
Rneasy RNA miniprep extraction kit (Qiagen) according to the
manufacturer’s instructions. The purification included a DNAse I
treatment step to remove contaminating DNA. Total RNA
concentrations were calculated from absorbance reading at
260 nm using a GeneQuant (Amersham Biosciences) and the
RNA quality for 1 representative sample of each tissue was verified
using an agilent chip (Agilent). 1 mg of freshly isolated RNA was
reverse transcribed using MMLV reverse transcriptase and random
hexamers. Briefly, 1 mg of RNA wasincubated for 5 minutesat70uC
in the presence of 0.5 mg of random hexamer primers and then
cooledonice.Oncecooled,themixwasincubatedwithamastermix
containing 0.5 mM of each dNTP, 24 units of Rnase inhibitor and
200 units of Moloney-murine leukemia virus (M-MLV) reverse
transcriptase,for1 hourat37uCfollowedbyadenaturationstep of5
minutes at 95uC. All enzymes were from Promega.
Real Time oligonucleotide primers were designed using the
primer express 2.0 software (Applied Biosystems) under default
parameters and using predicted sequences from the equine
genome [20]. The oligonucleotides were: Muc5b forward: 59-GT-
GGAGCAGAGCAGCGTCTAC-39, Muc5b reverse: 59-GCTCC-
AGCAGGGCACTGT-39, Muc5ac forward: 59-GATTCTGAGC-
GAGGTCTTCGA-39, Muc5ac reverse: 59-GGAGCACACCAC-
GTCCAAGT-39. Oligonucleotides were also designed for two
housekeeping genes, succinate dehydrogenase complex subunit A
(SDHA, sequence: XM_001490889, forward primer: 59-ACA-
GAGGAATGGTCTGGAAATACTGA-39, reverse primer 59-G-
TGAGCACCACGTGACTCCCTT-39), and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, sequence XM_001496020,
forward primer: 59-GTGTCCCCACCCCTAACGT-39, reverse
primer: 59-TCATCGTATTTGGCAGCTTTCTC-39). The
quantitative Real Time PCR assays were performed in triplicate
using a TaqMan
TM ABI PRISM 7900 (Applied Biosystems). Each
10 ml reaction volume consisting of 5 ml 2X (POWER SYBR
master mix (Applied Biosystems), 0.3 ml each of 20 mM forward
and reverse primers and 4.6 ml of sample cDNA or water (negative
control). Quantitative assays were validated using SYBR Green
chemistry. Assays were classed as validated if they had detection
ranges of at least five orders of magnitude, with an efficiency of
between 90 and 110% as measured by a standard curve slope of
between -2.95 and -3.62 (100% =3.3). Specificity of primer sets
was confirmed by the observation of single amplification products
of the expected size and melting temperature in all assays.
Expression of each gene was calculated from the geometric mean
of the CT of 2 housekeeping genes, GAPDH and SDHA using the
2-DCt method [60].
Polyclonal antisera
Polyclonal antisera were raised in rabbits against peptide
sequences located in putative the N-termini of equine Muc5b
and Muc5ac (MANeq5b-I; DEDYPTSEKAGGDIEC) and Mu-
c5ac (MANeq5ac-I; GIDSGDFDTLENLR). Two rabbits were
immunised per peptide and immunization consisted of four
injections of each peptide conjugated to KLH (antisera were
commissioned from Eurogentec). Antisera were purified using
Protein A. In brief, 25 mg of protein A Sepharose was mixed with
1 ml of antiserum diluted 1:2 in binding buffer (0.1 M tris-HCl
pH 7.5) and mixed overnight at 4uC. The unbound molecules
were eluted with PBS and the immunoglobulins were eluted twice
using 0.5 ml of 0.1 M glycine solution at pH 5 and 2.5, twice
using 0.1 M Tris-HCl pH 8, and finally twice with 100 mM TAE
at pH 11. All fractions were collected into tubes containing 50 ml
of 1 M Tris-HCl pH 8. The immunoreactivity of each fraction
was tested on Western blots of salivary and gastric mucus
separated by agarose gel electrophoresis, and by immunohisto-
chemical staining of the relevant tissues.
Histological and immunohistochemical staining
Epithelial tissues were collected from euthanased horses and
immediately fixed in formalin or ethanol. After dehydration with
xylene, the samples were then embedded in wax and 5 mm sections
cut. Prior to sectioning, tracheal tissue was treated for 1 h with 1:1
Da Castors solution (5% nitric acid and 50% methanol in water)
and Baker’s solution (10% glycerol and 50% methanol in water) to
decalcify the tissue. Sections from each tissue were stained with
periodic acid Schiff’s and alcian blue pH 2.5 (PAS-AB). For
immunohistochemical staining, sections were dewaxed and
microwaved for 5 minutes at 500 W with antigen retrieval
solution (10 mM sodium citrate pH 6). The sections were left to
cool prior to reduction with 10 mM dithiotreitol (DTT) and
alkylation with 25 mM iodoacetamide in 0.1 M Tris-HCl pH 8;
each treatment was applied for 30 minutes. Endogenous
peroxidase activity was quenched with 3% (v/v) hydrogen
peroxide in methanol for 30 minutes at room temperature. The
tissue sections were blocked with 10% (v/v) donkey serum and 1%
(w/v) bovine serum albumin in PBS (blocking solution) for one
hour prior to incubation with protein A-purified mucin-specific
antibodies (diluted 1 in 100 in the blocking solution for 1 hour at
room temperature). Sections were then incubated for 30 minutes
with biotin labelled donkey anti-rabbit IgG (Santa Cruz), diluted
1:250 in the blocking solution, and then treated with streptavidin
(ABC Kit Elite standard, VectaStain) for 30 minutes prior to
detection with Diaminobenzidine (Sigma). All sections were
counterstained with Harris’s haematoxylin and representative
pictures were taken using an Axiovision microscope. Goblet cell
counts were performed to assess the number of surface epithelial
goblet cells that stained with PAS, MANeq5ac-I and MANeq5b-I.
ImageJ software was used to assess the percentage of the area of
the submucosal glands stained with PAS, MANeq5ac-I and
MANeq5b-I. The level of statistical significance was determined
using the student’s t-test.
Mucin purification
Mucus samples were collected at an equine abattoir, within 20
minutes after death; these horses were healthy and had no
identifiable respiratory disease. The mucus was collected by
scraping the stomach and immediately mixed with 8 M guanidi-
nium chloride and the mucins were extracted with gentle stirring
for 4 days at 4uC. Horse saliva was collected and treated in an
identical fashion. Mucins were purified by caesium chloride
density gradient in 4 M guanidinium chloride at a starting density
of 1.4 g/ml and centrifuged for 65 h at 40000 rpm in a Beckman
Ti45 rotor as previously described [20].
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Mucins purified by density gradient centrifugation were reduced
and carboxymethylated as previously described [61] using 10 mM
DTT (one hour at 37uC) followed by 25 mM iodoacetamide (10
minutes at room temperature in the dark); and dialysed into 6 M
urea. The reduced and carboxymethylated mucins were subjected
to anion exchange chromatography on a Resource Q column
(1 ml 6 1 ml, Amersham). Briefly, mucins were bound to the
column using 10 mM piperazine pH 5 in 6 M urea. Fractions of
0.5 ml were eluted with an increasing concentration of 0.4 M
lithium perchlorate/10 mM piperazine, pH 5 in 6 M urea (0–
100%, total volume 30 ml). After chromatography selected
fractions were subjected to agarose gel electrophoresis.
Rate-zonal centrifugation
Mucins purified by density gradient centrifugation were
analysed by rate-zonal centrifugation on 6–8 M guanidinium
chloride gradients as described previously [20]. Unreduced mucins
were centrifuged in a SW40Ti swing-out rotor at 40000 rpm for
2.5 h and reduced mucins at 40000 rpm for 7 h.
Agarose gel electrophoresis and Western blotting
The samples, dialysed into 6 M urea, were electrophoresed on
0.7% agarose gels in 40 mM Tris acetate, 1 mM EDTA, pH 8.0
containing 0.1% (w/v) SDS. The gels were run for 3 h at 65 V.
After electrophoresis, the proteins were vacuum blotted onto
nitrocellulose membrane with a vacuum blotter; 40mbar pressure
in 0.6 M sodium chloride, 60 mM sodium citrate [62]. Mucins
were detected with the equine mucin specific antisera and an
alkaline phosphatase conjugated secondary antibody; blots were
developed with a NBT/BCIP solution for 1 minute.
Mass spectrometry for mucin identification
Following trypsin digestion of mucins, peptides were concen-
trated and desalted using solid phase extraction with ZipTips
(Millipore). The peptides were separated using a 0.0756250 mm
BEH UPLC column (Waters) on a nanoAcquity liquid chroma-
tography system (Waters) before being automatically analysed
on an LTQ Velos ion trap mass spectrometer (Thermo). The
data produced was searched using Mascot software (Matrix
Science) against a custom database containing SwissProt
database (EBI) and equine mucin sequences determined in our
laboratory.
Tracheal wash samples
In order to examine mucin content in the context of mucus
hypersecretion, we used aliquots of archived frozen tracheal
washes, which had been collected as part of a wider longitudinal
study of IAD in National Hunt racehorses conducted by the two
authors Drs Cardwell & Newton [36,37].
For each sample, a mucus score was assigned during endoscopic
examination according to Gerber et al [63] (Score 0: no visible
mucus, score 1: small amount, isolated flecks, score 2: moderate
amounts, multiple larger blobs, and score 3: large amounts visible,
larger blobs at least partly confluent). In addition, the types and
number of bacteria present in each tracheal wash had been
determined immediately after return of samples on ice in a cool
box to the laboratory. Briefly, samples were serially diluted in PBS
(10
21,1 0
22,1 0
23 and 10
24) and 0.1 ml was spread onto, a
selective medium for Streptococci (colistin oxolinic acid blood agar
[64]) and anaerobic horse blood agar solid bacteriological media.
The total number of colonies of each bacterial species separately
and of all bacteria in total were calculated and expressed as log10
number of colony forming units per ml (cfu/ml) of undiluted
sample.
Drs Cardwell & Newton’s study consisted of an overall total of
1184 samples collected monthly from 177 horses during the study
[36,37], with the number of samples from each horse varying
between 1 and 15 samples. For the present study, samples with
high mucus scores were selected (all those still available); this
represented 18 samples collected from 16 different horses (15
samples with a mucus score of 2 and 3 samples with a mucus score
of 3). Lower mucus score samples were used as control and
corresponded to the other samples collected from the aforemen-
tioned 16 horses.
Relative quantitation of Muc5b and Muc5ac in tracheal
wash samples
Each tracheal wash sample was dissolved in 5 volumes of 8 M
guanidinium chloride for at least 5 days, and dialysed against
6 M urea. Using a method similar to that published by Kirkham
et al [25], several dilutions of each sample, prepared using a
Hamilton syringe for accuracy, were analysed by agarose gel
electrophoresis followed by Western blotting with the MANeq5b-
I and MANeq5ac-I antisera. The antibody response for each
dilution was measured using a Biorad Model GS 800 calibrated
densitometer.
Preparation Muc5ac and Muc5b mucin standards
Gastric mucus and saliva were solubilised in 8 M guanidinium
chloride and the mucins purified by caesium chloride density
gradient purification [20] followed by anion exchange chroma-
tograpy as described above. Refractometry was used to determine
to concentration of the mucin solutions, in brief, samples were
chromatographed on a Superose 6 column (0.8 cm 630 cm)
eluted at a flow rate of 0.83 ml/min with 0.2 M NaCl/1 mM
EDTA. The column effluent was monitored with an in-line
Optilab rEX refractometer (Wyatt Technology Corporation,
Haverhill, Suffolk, UK) using a dn/dc value of 0.165. Tandem
mass spectrometry of trypsin digested mucins (as described above)
was used to identify the mucins present in the preparations. The
salivary mucin preparation which contained a mixture of Muc5b
and Muc19 mucins was further analysed by tandem mass
spectrometry to determine the ratio of Muc5b/Muc19. In brief,
3 separate aliquots of the purified mucin solution were digested
with trypsin and analysed by tandem mass spectrometry; the
number of occasions that each peptide had a spectral match
(number of spectra per peptide) was used to determine the most
abundant peptides. The mass to charge ratios of each of the three
most abundant peptides were used to create extracted ion
chromatograms using Xcaliber software (Thermo) and the identity
of each peak checked by matching the relevant fragmentation
spectra to the database matched versions. The sum peak area or
height was calculated for each mucin peptide in each sample and
the ratio of these sum values was considered to reflect the relative
protein concentrations of the two mucins [38].
Statistical analyses
SPSS v16 software was used to conduct statistical analyses with
P#0.05 considered statistically significant. The association be-
tween the ordinal Muc5ac and Muc5b mucin scores and
continuous Muc5b and Muc5ac antibody reactivities was
examined by ANOVA. Pearson’s correlation test was used to
determine the correlation between the reactivities of Muc5ac and
Muc5b, as well as the correlation between mucins antibody
response and continuous log10 bacterial count.
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